Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Zscaler Inc.'s published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $24.5B | |
|---|---|---|
| Revenue (ttm) | 3.4B | |
| Net income (ttm) | -63.2M | |
| EPS (ttm) | -$0.39 | |
| Shares out | 163.1M | |
| P/E (forward) | 33.2x | |
| Volume | 2,065,531 | |
| Beta | 0.94 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | Trend |
|---|---|---|---|---|---|
| Period | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | Trend |
| Revenue | $1.09B | $1.62B | $2.17B | $2.67B | +34.8% |
| Gross profit | $848.7M | $1.25B | $1.69B | $2.05B | +34.3% |
| Operating income | $-327.1M | $-176.0M | $-16.1M | $-13.1M | — |
| Net income | $-390.3M | $-202.3M | $-57.7M | $-41.5M | — |
| EPS (diluted) | $-2.77 | $-1.40 | $-0.39 | $-0.27 | — |
| EBITDA | $-277.6M | $-109.2M | $64.8M | $108.1M | — |
| R&D | $289.1M | $350.8M | $499.8M | $672.5M | +32.5% |
| SG&A | $887.0M | $1.14B | $1.31B | $1.51B | +19.4% |
Recent company headlines from major financial publishers.
Zero Trust adoption accelerates, keeping revenue growth >20% for longer. Operating leverage kicks in as sales and marketing efficiencies improve, driving operating margins toward the 30% industry benchmark and supporting a premium multiple.
The company sustains mid-to-high teens revenue growth over the medium term. Operating leverage materializes gradually, though persistent SBC limits immediate GAAP profitability. Fair value assumes strict normalization to industry average margins.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 9.3% | $205 | $220 | $237 | $258 | $282 |
| 10.3% | $180 | $192 | $205 | $220 | $237 |
| 11.3% | $161 | $170 | $180 | $192 | $205 |
| 12.3% | $145 | $153 | $161 | $170 | $180 |
| 13.3% | $132 | $139 | $145 | $153 | $161 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
